References
- Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9(Suppl 2)59–69
- Malfertheiner P. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 1997; 41: 8–13
- McColl KE, Murray L, Gillen D, Walker A, Wirz J, Mowat C, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. Br Med J 2002; 324: 999–1002
- Heaney A, Collins JSA, Watson PRG, McFarland JR, Bamford KB, Tham TCK. A prospective randomised trial of a “test and treat” policy versus endoscopy-based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999; 45: 186–90
- Moayyedi P, Ziller A, Cloough M, Hemmingbrough E, Chalmers DM, Axon AT. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia. Eur J Gastroenterol Hepatol 1999; 11: 1245–50
- Blum A, Talley NJ, O'Morain C, Veldhuyzen van Zanten S, Labenz J, Stolte M. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998; 339: 1875–81
- Danesh J, Pounder RE. Eradication of Helicobacter pylori and non-ulcer dyspepsia. Lancet 2000; 355: 766–7
- Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. Ann Intern Med 2001; 134: 361–9
- Miwa H, Hirai S, Nagahara A, Murai T, Nishira T, Kikuchi S, et al. Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000; 14: 317–24
- Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Br Med J 2000; 321: 659–64
- Sonnenberg A. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects. Am J Gastroenterol 1996; 91: 1773–7
- Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999; 43: 459–65
- Kunin CM. Resistance to antimicrobial drugs: a worldwide calamity. Ann Intern Med 1993; 118: 557–61
- Levy SB. Confronting multidrug resistance. A role for each of us. JAMA 1993; 269: 1840–2
- Delaney B, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A, et al. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. Br Med J 2001; 322: 1–5
- Patel P, Khulusi S, Mendall MA, Lloyd R, Jazrawi R, Maxwell JD, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995; 346: 1315–8
- Sobala GM, Crabtree JE, Pentith JA, Rathbone BJ, Shallcross TM, Wyatt JI, et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94–6
- Vaira D, Stanghellini V, Menegatti D, Palli D, Corinaldesi R, Miglioli M, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy?. Endoscopy 1997; 29: 595–601
- Asante MA, Mendall MA, Patel P, Ballam L, Northfield TC. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998; 10: 983–9
- Asante MA, Lord J, Mendall MA, Northfield TC. Endoscopy for Helicobacter pylori seronegative young dyspeptic patients: an economic evaluation based on a randomized trial. Eur J Gastroenterol Hepatol 1999; 11: 851–6
- Breslin NP, Lee J, Buckley M, O'Morain C. Screening for Helicobacter pylori in young dyspeptic patients referred for investigation: endoscopy for those who test negative. Aliment Pharmacol Ther 1998; 12: 577–82
- Gisbert JP, Pajares JM. Helicobacter pylori “Test-and-scope” strategy for dyspeptic patients. Helicobacter 2000; 5: 57–68
- Wu J, Sung J. Ulcer and gastritis. State of the art. Endoscopy 2002; 34: 104–10
- Working Party of the European Helicobacter pylori Study Group. Guidelines for clinical trials in Helicobacter pylori infections. Gut 1997;41 (Suppl 2):S1–S23.
- British Society of Gastroenterology. Dyspepsia management guidelines. London: 1996.
- Manes G, Menchise A, de Nucci C, Balzano A. Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment. Br Med J 2005; 326: 1118
- Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. Br Med J 2005; 324: 1012
- Weijnen CF, Numans ME, de Wit NJ, Smout AJ, Moons KG, Verheij TJ, et al. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross-sectional study. Br Med J 2001; 323: 71–5
- Ford AC, Qume M, Moayyedi P, Arents NLA, Lassen AT, Logan R, et al. Helicobacter pylori “test and treat” or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 2005; 128: 1838–44
- Lassen AT, Hallas J, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow-up of a randomised trial. Gut 2004; 53: 1758–63
- Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000; 356: 455–60
- Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579–87
- Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. Scand J Gastroenterol 1999; 34: 353–60
- Eggers RH, Kulp A, Tegeler R, Lüdtke FE, Lepsien G, Meyer B, et al. A methodogical analysis of the 13C-urea breath test for detection of Helicobacter pylori infections: high sensitivity and specificity within 30 min using 75 mg of 13C-urea. Eur J Gastroenterol Hepatol 1990; 2: 437–44
- Epple HJ, Kirstein FW, Bojarski C, Frege J, Fromm M, Riecken O, et al. C-urea breath test in Helicobacter pylori diagnosis and eradication. Scand J Gastroenterol 1997; 32: 308–14
- McNulty C, Teare L, Owen R, Tompkins D, Hawtin P, McColl KE. Test and treat for dyspepsia – but which test?. Br Med J 2005; 330: 105–6
- Axon AT, Bell GD, Jones RH, Quine MA, McCloy RF. Guidelines on appropriate indications for upper gastrointestinal endoscopy. Br Med J 1995; 310: 853–6
- Dent J. Management of reflux disease. Gut 2002; 50(Suppl 4)67–71
- Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. An evidence-based appraisal of reflux disease management – the Genval Workshop Report. Gut 1999; 44(Suppl 2)S1–S16
- Stål P, Lindberg G, Øst Å, Iwarzon M, Seensalu R. Gastroesophageal reflux in healthy subjects: significance of endoscopic findings, histology, age, and sex. Scand J Gastroenterol 1999; 34: 121–8